Seagen is now part of Pfizer! Please visit Pfizer.com for more information.. For US residents only.

Check here to skip this screen and always use Native Client.

You should not rely on the materials in deciding on a treatment plan, drug usage, or any other medical advice regarding the materials, and Seagen strongly urges that you consult with a physician in connection with any and all treatment options that may be available to you.

BOTHELL, Wash., Sep 22, 2009 (BUSINESS WIRE) - Seattle Genetics, Inc. (Nasdaq:SGEN) announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, …

We believe that embracing the uniqueness of all our people allows us to build on our legacy of innovation and bring transformative therapies to people living with cancer.

We would like to show you a description here but the site won’t allow us.

This Privacy Policy describes the privacy practices of Seagen Inc., and its affiliates (collectively, “we,” “us,” or “our”).

At Seagen, we represent much more than just a team of scientists and researchers. Many of us have been personally touched by cancer, and that’s what motivates the work we do. This is why we work so hard to understand the needs and expectations of the patient communities we serve.

Since our founding in 1998, we’ve worked to create a culture we can be proud of. We prioritize opportunities to build community, respect, and collaboration—whether it’s through volunteering, after-work sports, or clinical problem solving.

Sep. 14, 2015- Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that the underwriters of its previously announced public offering of common stock have exercised in full their over-allotment option to purchase an additional 1,756,097 shares of common stock. Including this option exercise, total gross proceeds from the offering of an aggregate of 13,463,415 shares …